Ayaz, N. Et Al. 2020. Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. Rheumatology International , vol.40, no.7 , 1111-1116.

Ayaz, N., Karadağ, Ş. G., Koç, R., Demirkan, F. G., Çakmak, F., & Sönmez, H., (2020). Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. Rheumatology International , vol.40, no.7, 1111-1116.

Ayaz, Nuray Et Al. "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study," Rheumatology International , vol.40, no.7, 1111-1116, 2020

Ayaz, Nuray A. Et Al. "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study." Rheumatology International , vol.40, no.7, pp.1111-1116, 2020

Ayaz, N. Et Al. (2020) . "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study." Rheumatology International , vol.40, no.7, pp.1111-1116.

@article{article, author={Nuray AKTAY AYAZ Et Al. }, title={Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study}, journal={Rheumatology International}, year=2020, pages={1111-1116} }